Company intelligence
Alzheimer's Disease Data Initiative
Dedicated to advancing scientific breakthroughs in the treatment of Alzheimer's disease and related dementias.
About Alzheimer's Disease Data Initiative
Dedicated to advancing scientific breakthroughs in the treatment of Alzheimer's disease and related dementias
Verified activity
Signals from Alzheimer's Disease Data Initiative
7 published signals
Research & Knowledge
Alzheimer's Disease Data Initiative published a study using plasma proteomics data from the Bio-Hermes cohort and AD Workbench trained machine learning models on 988 participants to distinguish amyloid PET-positive from amyloid PET-negative individuals.
Reported by Alzheimer's Disease Data Initiative
Research & Knowledge
Alzheimer's Disease Data Initiative is building a consortium S|GN to bring global experts, datasets, and multiple hypotheses to help accelerate the generation of insights.
Reported by Niranjan Bose
Research & Knowledge
Alzheimer's Disease Data Initiative co-authored a paper in Nature Aging introducing S|GN, an AD Data Initiative Driver Project working to mine existing data and generate new insights from available biosamples through a sex and gender lens.
Reported by Alzheimer's Disease Data Initiative
Research & Knowledge
Alzheimer's Disease Data Initiative published new research on AD Workbench showing that female caregivers spend $191.80 more per month on informal care than male caregivers and report significantly higher burden.
Reported by Alzheimer's Disease Data Initiative
Research & Knowledge
Alzheimer's Disease Data Initiative released data from the ALFA+ longitudinal study available to researchers via AD Workbench.
Reported by Alzheimer's Disease Data Initiative
Partnerships
Alzheimer's Disease Data Initiative entered into a partnership with Arcadi Navarro Marc Suárez-Calvet and Barcelona Beta Brain Research Center colleagues to make the ALFA+ longitudinal study available on the AD Workbench.
Reported by Niranjan Bose
Research & Knowledge
Alzheimer's Disease Data Initiative published a study by Guglielmo di Molfetta and co-authors of Banner Health identifying an alternative diagnostic pathway for advanced Alzheimer's pathology using a new blood test panel that improved diagnostic accuracy and reduced ambiguous results.
Reported by Alzheimer's Disease Data Initiative